These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34379039)

  • 1. Isotretinoin for acne vulgaris - an update on adverse effects and laboratory monitoring.
    Fallah H; Rademaker M
    J Dermatolog Treat; 2022 Aug; 33(5):2414-2424. PubMed ID: 34379039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing nonteratogenic adverse reactions to isotretinoin treatment for acne vulgaris.
    Reilly BK; Ritsema TS
    JAAPA; 2015 Jul; 28(7):34-9. PubMed ID: 26107793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness Of Oral Omega 3 In Reducing Mucocutaneous Side Effects Of Oral Isotretinoin In Patients With Acne Vulgaris.
    Zainab Z; Malik NA; Obaid S; Malik S; Aftab K; Mumtaz M; Pervez A; Syed Z
    J Ayub Med Coll Abbottabad; 2021; 33(1):60-63. PubMed ID: 33774956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Second joint position paper: Use of isotretinoin in severe acne].
    Gómez-Flores M; Poletti-Vázquez DE; García-Hidalgo L; Fierro-Arias L; Herz-Ruelas M; Garza-Gómez J; Rosas-Ortiz JF
    Rev Med Inst Mex Seguro Soc; 2019 Jan; 56(5):441-446. PubMed ID: 30777411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isotretinoin in the management of acne vulgaris: practical prescribing.
    Fallah H; Rademaker M
    Int J Dermatol; 2021 Apr; 60(4):451-460. PubMed ID: 32860434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin E does not reduce the side-effects of isotretinoin in the treatment of acne vulgaris.
    Kus S; Gün D; Demirçay Z; Sur H
    Int J Dermatol; 2005 Mar; 44(3):248-51. PubMed ID: 15807739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oral adverse effects of isotretinoin treatment in acne vulgaris patients: A prospective, case-control study.
    Erdemir U; Okan G; Gungor S; Tekin B; Yildiz SO; Yildiz E
    Niger J Clin Pract; 2017 Jul; 20(7):860-866. PubMed ID: 28791981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of clinical adverse effects and laboratory alterations in patients with acne vulgaris treated with oral isotretinoin.
    Brito Mde F; Sant'Anna IP; Galindo JC; Rosendo LH; Santos JB
    An Bras Dermatol; 2010; 85(3):331-7. PubMed ID: 20676466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isotretinoin: dose, duration and relapse. What does 30 years of usage tell us?
    Rademaker M
    Australas J Dermatol; 2013 Aug; 54(3):157-62. PubMed ID: 23013115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New onset of axial spondyloarthropathy in patients treated with isotretinoin for acne vulgaris: incidence, follow-up, and MRI findings.
    Elnady B; Elkhouly T; Dawoud NM; Desouky DE; Kewan HH; Dawoud DM; Ritchlin C
    Clin Rheumatol; 2020 Jun; 39(6):1829-1838. PubMed ID: 32034553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isotretinoin updates.
    On SC; Zeichner J
    Dermatol Ther; 2013; 26(5):377-89. PubMed ID: 24099068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris.
    Blasiak RC; Stamey CR; Burkhart CN; Lugo-Somolinos A; Morrell DS
    JAMA Dermatol; 2013 Dec; 149(12):1392-8. PubMed ID: 24173086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimize the regular laboratory monitoring during the systemic isotretinoin treatment: data of 704 patients with acne vulgaris.
    Öktem A; Hayran Y; Arı E; Yalçın B
    J Dermatolog Treat; 2019 Dec; 30(8):813-817. PubMed ID: 30836808
    [No Abstract]   [Full Text] [Related]  

  • 14. Alleged isotretinoin-associated inflammatory bowel disease: disproportionate reporting by attorneys to the Food and Drug Administration Adverse Event Reporting System.
    Stobaugh DJ; Deepak P; Ehrenpreis ED
    J Am Acad Dermatol; 2013 Sep; 69(3):393-8. PubMed ID: 23683730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral isotretinoin in the treatment of juvenile acne and psychiatric adverse effects - a systematic review.
    Fernandes T; Magina S
    Cutan Ocul Toxicol; 2023 Sep; 42(3):83-90. PubMed ID: 37343232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory Monitoring During Isotretinoin Therapy for Acne: A Systematic Review and Meta-analysis.
    Lee YH; Scharnitz TP; Muscat J; Chen A; Gupta-Elera G; Kirby JS
    JAMA Dermatol; 2016 Jan; 152(1):35-44. PubMed ID: 26630323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of sacroiliitis in patients with acne vulgaris using isotretinoin.
    Baykal Selçuk L; Aksu Arıca D; Baykal Şahin H; Yaylı S; Bahadır S
    Cutan Ocul Toxicol; 2017 Jun; 36(2):176-179. PubMed ID: 27764978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular side effects of systemic isotretinoin - a systematic review and summary of case reports.
    Lamberg O; Strome A; Jones F; Mleczek J; Jarocki A; Troost JP; Helfrich Y
    J Dermatolog Treat; 2023 Dec; 34(1):2213364. PubMed ID: 37248700
    [No Abstract]   [Full Text] [Related]  

  • 19. Psychological impact of isotretinoin treatment in patients with moderate and severe acne.
    Simić D; Situm M; Letica E; Penavić JZ; Zivković MV; Tomić T
    Coll Antropol; 2009 Dec; 33 Suppl 2():15-9. PubMed ID: 20120397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isotretinoin: update on controversial issues.
    Prevost N; English JC
    J Pediatr Adolesc Gynecol; 2013 Oct; 26(5):290-3. PubMed ID: 24147278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.